BUD : Summary for Anheuser-Busch Inbev SA Sponsor - Yahoo Finance

U.S. Markets closed

Anheuser-Busch InBev SA/NV (BUD)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
103.54+0.89 (+0.87%)
At close: 4:02 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close102.65
Bid103.02 x 1000
Ask103.40 x 500
Day's Range102.93 - 103.55
52 Week Range98.28 - 136.08
Avg. Volume2,312,825
Market Cap166.47B
PE Ratio (TTM)55.25
Earnings DateN/A
Dividend & Yield3.41 (3.32%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal8 hours ago

    Anheuser-Busch InBev to Consider Ad Buying Review for 2017

    Anheuser-Busch InBev NV is considering a review of its massive global ad buying business following its recent $100 billion-plus takeover of beer giant SABMiller.

  • Altria Group Inc.'s Best Move in 2016
    Motley Fool14 hours ago

    Altria Group Inc.'s Best Move in 2016

    The way the tobacco giant handled one key opportunity stood head and shoulders above the rest.

  • American City Business Journals18 hours ago

    Columbus to be U.S. test market for Anheuser-Busch study on problem drinking

    Anheuser-Busch InBev is tapping Columbus as a test market, but not for a new beer. The Belgium-based brewer alongside the city of Columbus and Columbus Public Health will conduct a citywide study on the harmful use of alcohol and how that can be reduced. “Through our research, we are aiming to truly understand our community needs and provide evidence-based programs to have a positive impact on a range of behaviors including binge drinking, drunk driving and underage drinking,” Columbus Health Commissioner Dr. Teresa Long said in a release from the city.